London calling: Limited places available for final Nobel Biocare symposium of 2017
Dental professionals have one last chance this year to experience the high-quality educational experience of a Nobel Biocare symposium when the final event of the 2017 series takes place in in London, UK, November 10–11.
A limited number of places are still available for the event, which will be held at the Millennium Gloucester Hotel. The symposium will offer lectures and master classes from both globally renowned experts and the leading local names in implantology.
Speakers include Dr. Rubén Davó from Alicante, Spain, who will present the new Trefoil system for the first time in the UK. Launched on October 5, the Trefoil system is a breakthrough in efficiency for treating the edentulous mandible, enabling a fixed and definitive prosthesis on the day of surgery.1
As a principal investigator in an international multi-center study of the Trefoil system conducted prior to launch, Dr. Davó is one of very few clinicians in the world already experienced in treating patients with this latest Nobel Biocare innovation.
The latest techniques for the treatment of edentulous patients and those with a failing dentition will also be addressed on stage by Prof. Paulo Malo, from Lisbon, Portugal–the pioneer of the original, proven All-on-4® treatment concept–and London-based Dr. Andrew Dawood, who will present the management of the atrophic maxilla using zygomatic implants.
Other highlights include a comprehensive program covering the integrated digital workflow. Nobel Biocare’s collaborative workflow has been developed to significantly increase treatment efficiency and patient acceptance with the latest digital innovations.2,3 International speakers on the topic include Switzerland’s Dr. Roland Glauser and Drs. Leon Pariente and Karim Dada of Paris, France, who will discuss these latest digital trends shaping implantology and their benefits.
Over 6,000 dental professionals have attended the 10 Nobel Biocare symposia held already this year, with hundreds more expected in London.
Those looking to view the full program, or to register for the Nobel Biocare symposium in London, should visit nobelbiocare.com/London
What attendees of previous Nobel Biocare 2017 symposia had to say:
“Nobel Biocare doesn’t present products, but solutions. Once again they surprised us with the new solutions that are now available. These will continue to help us in our daily practice, making things easy and simple, with better solutions for the clinic and, naturally, for our patients.” Dr. Pedro Santos Silva, Portugal
“The Next Generation session was a wonderful surprise, it’s good to see young speakers with such good presentations, they are our future. Congratulations to Nobel Biocare on the event!” Dr. Alexandre Rovisco, Portugal
"I would like to thank Nobel Biocare for the perfect organization of the Dubai Symposium. The scientific program was outstanding, as the renowned clinicians lecturing succeeded in relating how Nobel Biocare has always joined science and innovative technologies in the constant evolution of their products to better serve the dentists and their patients." Prof. Nabil Barakat, Lebanon
“We enjoyed a top-level scientific program. Highlights were the interdisciplinary approach, the live surgeries and also an excellent program for the laboratory technicians who play a very important role in treatment – this is crucial for the benefit of the patients.” Dr. Beatriz Aranguena, Spain
“Nobel Biocare events are always interesting – lecturers from all over the world providing different concepts and approaches are widely represented here. They help to follow trends in the contemporary dental market and to be at the cutting edge, both clinically and scientifically.” Dr. Ivan Kondratiev, Russia
“The Nobel Biocare symposium in China has been well organized with fantastic academic topics. It provides dentists with a good chance to be exposed to the latest ideas and technologies of the dental implant industry.” Prof. Ye Lin, China
1. Depending on clinician preference and close cooperation with the laboratory.
2. Imburgia M. Patient and team communication in the iPad era – a practical appraisal. Int J Esthet Dent 2014,9(1): 26-29
3. Imburgia M, Coachman C. Using digital devices to improve communications between clinicians and patients during implant- prosthetic treatment: a clinical study [#519]. 23rd Annual Scientific Meeting of the European Association for Osseointegration. Rome, Italy: Wiley; 2014. p.538
Disclaimer: Some products may not be regulatory cleared/released for sale in all markets. Dental professionals should contact the local Nobel Biocare representative for current product assortment and availability.
Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and NobelGuide®) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at five sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.